Dysfunctional uterine bleeding in adolescents

Current Opinion in Pediatrics

Volumn 8, Issue 4, 1996, Pages 328-332

  Lavin, Claudia ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; ETHINYLESTRADIOL; FOLIC ACID; FOLLITROPIN; GESTAGEN; GONADORELIN DERIVATIVE; IRON; LUTEINIZING HORMONE; MEDROXYPROGESTERONE; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; PROSTAGLANDIN INHIBITOR;

ANOVULATION; CLINICAL TRIAL; DIET SUPPLEMENTATION; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; MENORRHAGIA; ORAL DRUG ADMINISTRATION; OVULATION INDUCTION; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; UTERUS BLEEDING;

EID: 0029844942     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199608000-00005     Document Type: Review

References (26)

1. Treolar AD, Boynton RE, Behn BG, Brown BW: Variation of the human menstrual cycle during reproductive life. Int J Fertil 1967, 12:77-126.
2. Apter D, Vihko R: Early menarche, a risk factor for breast cancer, indicates early onset of ovulatory cycles. J Clin Endocrinol Metab 1983, 57:82-86.
3. Hallberg L, Hogdahl AM, Nilsson L, Ribo G: Menstrual blood loss: a population study. Acta Obstet Gynecol Scand 1966, 45:320-351.
4. Brawner NA, Kehler CS: Abnormal uterine bleeding in the adolescent. Adolesc Med State Art Rev 1994, 5:157-170.
5. Hertweck PS: Dysfunctional uterine bleeding. Obstet Gynecol Clin North Am 1992, 19:129-149.
6. Wathen PI, Henderson MC, Witz CA: Abnormal uterine bleeding. Med Clin North Am 1995, 79:329-342. A current review of abnormal uterine bleeding using a descriptive terminology that describes the underlying abnormality.
7. Bayer SR, DeCherney AH: Clinical manifestations and treatment of dysfunctional uterine bleeding. JAMA 1993, 269:1823-1828.
8. Fraser IS: Menorrhagia: a pragmatic approach to the understanding of causes and the need for investigations. Br J Obstet Gynaecol 1994, 101:3-7.
9. Krettek JE, Arkin SI, Chaisilwattana P, Monif GRG: Chlamydia trachomatis in patients who used oral contraceptives and had intermenstrual spotting. Obstet Gynecol 1993, 81:728-731.
10. Durinzi KL, DeLeon FD: Endometriosis in the adolescent and teenage female. Adolesc Pediatr Gynecol 1993, 6:3-7.
11. Claessens EA, Cowell CA: Acute adolescent menorrhagia. Am J Obstet Gynecol 1981, 139:277-280.
12. Falcone T, Desjardins C, Bourque J, Granger L, Hemmings R, Quiros E: Dysfunctional uterine bleeding in adolescents. J Reprod Med 1994, 39:761-764.
13. Steinkampf PM: Systemic illness and menstrual dysfunction. Obstet Gynecol Clin North Am 1990, 17:311-319.
14. Cowan BD, Morrison JC: Management of abnormal genital bleeding in girls and women. N Engl J Med 1991, 324:1710-1715.
15. Linsay A, Voorhess M, MacGillivray M: Multicystic ovaries detected by sonography in children with hypothyroidism. Am J Dis Child 1993, 134:588-591.
16. Wilansky DL, Greisman B: Early hypothyroidism in patients with menorrhagia. Am J Obstet Gynecol 1989, 160:673-677.
17. Batrinos ML, Panitsa-Faflia C, Courcoutsakis N, Chatzipalov V: Incidence, type, and etiology of menstrual disorders in the age group 12-19 years. Adolesc Pediatr Gynecol 1990, 3:149-153.
18. Ibañez L, Potau N, Zampolli M, Prat N, Gussinye M, Saenger P, Vincens Calvet E, Carrascosa A: Source localization of androgen excess in adolescent girls. J Clin Endocrinol Metab 1994, 79:1778-1784.
19. Ehrmann DA, Barnes RB, Rosenfield RL: Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Metab 1995, 16:322-353. Excellent review of polycystic ovary syndrome.
20. Janssen CA, Scholten PC, Heintz PM: A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss. Obstet Gynecol 1995, 85:977-982. This study validates a simple visual assessment technique of menstrual blood loss and occurrence of anemia for predicting menorrhagia.
21. Fraser IS, Pearse C, Sherman RP: Efficacy of mefenamic acid in patients with a complaint of menorrhagia. Obstet Gynecol 1981, 58:543-551.
22. DeVore GR, Owens O, Kase W: Use of intravenous Premarin in the treatment of dysfunctional uterine bleeding. Obstet Gynecol 1982, 59:285-291.
23. Laufer MR, Rein MS: Treatment of abnormal uterine bleeding with gonadotropin-releasing hormone analogues. Clin Obstet Gynecol 1993, 36:668-678.
24. Surrey ES: Steroidal and nonsteroidal "add back" therapy: extending safety and efficacy of gonadotropin-releasing hormone agonists in the gynecologic patient. Fertil Steril 1995, 64:673-685. This article assesses the efficacy of various Steroidal and nonsteroidal add-back regimens to suppress associated hypoestrogenic side effects of long-term GnRH agonist therapy in gynecologic problems.
25. Southam AL, Ricart RM: The prognosis for adolescents with menstrual abnormalities. Am J Obstet Gynecol 1966, 94:637-642.
26. Farhi B, Nosanchok J, Silverberg S: Endometrial carcinoma in women under 25 years of age. Obstet Gynecol 1986, 68:741-744.